290 related articles for article (PubMed ID: 24918192)
21. HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
Chien CV
PLoS One; 2007 Mar; 2(3):e278. PubMed ID: 17372625
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of generic antiretroviral therapy.
Hirnschall G; de Joncheere C
Ann Intern Med; 2013 May; 158(10):776. PubMed ID: 23689769
[No Abstract] [Full Text] [Related]
23. Cost-effectiveness of generic antiretroviral therapy--in response.
Walensky RP; Paltiel AD; Schackman BR
Ann Intern Med; 2013 May; 158(10):776-7. PubMed ID: 23689770
[No Abstract] [Full Text] [Related]
24. Generic antiretrovirals and HIV care in the United States.
Cohn J
Ann Intern Med; 2013 May; 158(10):777. PubMed ID: 23689771
[No Abstract] [Full Text] [Related]
25. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
26. Generic antiretrovirals and HIV care in the United States--in response.
Sherer R
Ann Intern Med; 2013 May; 158(10):777-8. PubMed ID: 23689772
[No Abstract] [Full Text] [Related]
27. Generic antiretrovirals and the uncertain future of HIV care in the United States.
Sherer R
Ann Intern Med; 2013 Jan; 158(2):133-4. PubMed ID: 23318314
[No Abstract] [Full Text] [Related]
28. World CAB II. This time it's generic.
Huff B
GMHC Treat Issues; 2005; 19(3-4):10-5. PubMed ID: 16003845
[No Abstract] [Full Text] [Related]
29. Physicians say generic AIDS drugs don't threaten R&D.
AIDS Policy Law; 2002 Mar; 17(6):4. PubMed ID: 12004757
[No Abstract] [Full Text] [Related]
30. Generic nucleoside approved.
AIDS Patient Care STDS; 2005 Aug; 19(8):540. PubMed ID: 16163787
[No Abstract] [Full Text] [Related]
31. Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health.
Beck EJ; Passarelli C; Lui I; Guichard AC; Simao M; De Lay P; Loures L
Antivir Ther; 2014; 19 Suppl 3():117-23. PubMed ID: 25310477
[TBL] [Abstract][Full Text] [Related]
32. Working together to provide generics for health.
Beck EJ; Reiss P
Antivir Ther; 2014; 19 Suppl 3():1. PubMed ID: 25310234
[No Abstract] [Full Text] [Related]
33. [Generic antiretroviral drugs and their potential for cost reduction].
Stoll M
MMW Fortschr Med; 2018 Jun; 160(Suppl 2):37-39. PubMed ID: 29943329
[No Abstract] [Full Text] [Related]
34. Production of low cost AIDS drugs to continue in Brazil.
Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
[No Abstract] [Full Text] [Related]
35. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
Sante; 1999; 9(5):277-81. PubMed ID: 10657769
[TBL] [Abstract][Full Text] [Related]
36. Global fund decides to promote use of generic drugs.
Elliott R
Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):58-9. PubMed ID: 14740604
[No Abstract] [Full Text] [Related]
37. The generic drug approval process.
Rheinstein PH
Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762
[No Abstract] [Full Text] [Related]
38. Tobias, W.H.O. at odds over drug standards.
Med Health; 2004 Mar; 58(13):2-3. PubMed ID: 15088496
[No Abstract] [Full Text] [Related]
39. The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report.
Herrmann S; Wardrop J; John M; Gaudieri S; Lucas M; Mallal S; Nolan D
Sex Health; 2012 Nov; 9(5):407-13. PubMed ID: 22950904
[TBL] [Abstract][Full Text] [Related]
40. Paying for life. The issues behind drug pricing.
Huff B
GMHC Treat Issues; 2003 Nov; 17(11):1-7. PubMed ID: 14717105
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
